TAK1 is a Regulator of Sorafenib-induced Keratinocyte Toxicity

被引：0
|
作者：
Zimmerman, Eric I. [1 ]
Gibson, Alice A. [1 ]
Hu, Shuiying [1 ]
Berk, Jeffrey [1 ]
Orwick, Shelley [1 ]
Sparreboom, Alex [1 ]
Baker, Sharyn D. [1 ]
机构：
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
657.1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sorafenib-induced cardiovascular toxicity: A cause for concern
    Deng, Zheng
    Xiao, Shuang
    He, Ying-Ying
    Guo, Yu
    Tang, Li-Jing
    CHEMICO-BIOLOGICAL INTERACTIONS, 2025, 410
  • [2] TAK1 is an essential regulator of BMP signalling in cartilage
    Shim, Jae-Hyuck
    Greenblatt, Matthew B.
    Xie, Min
    Schneider, Michael D.
    Zou, Weiguo
    Zhai, Bo
    Gygi, Steven
    Glimcher, Laurie H.
    EMBO JOURNAL, 2009, 28 (14): : 2028 - 2041
  • [3] Sorafenib-induced pancreatitis
    Amar, Surabhi
    Wu, Kevin J.
    Tan, Winston W.
    MAYO CLINIC PROCEEDINGS, 2007, 82 (04) : 521 - 521
  • [4] Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications
    Li, Jue
    Zhang, Lusha
    Ge, Teng
    Liu, Jiping
    Wang, Chuan
    Yu, Qi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 829 - 843
  • [5] TAK1 Is a Key Regulator of Skeletal Muscle Maintenance in Mice
    Sato, Shuichi
    Hindi, Sajedah M.
    Tajrishi, Marjan M.
    Xiong, Guangyan
    Kumar, Ashok
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2016, 48 (05): : 15 - 15
  • [6] TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance
    Xia, Shunjie
    Ji, Lin
    Tao, Liye
    Pan, Yu
    Lin, Zhongjie
    Wan, Zhe
    Pan, Haoqi
    Zhao, Jie
    Cai, Liuxin
    Xu, Junjie
    Cai, Xiujun
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2021, 12 (03): : 1121 - 1143
  • [7] Sorafenib-induced erythema multiforme
    MacGregor, Jennifer L.
    Silvers, David N.
    Grossman, Marc E.
    Sherman, William H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (03) : 527 - 528
  • [8] Sorafenib-induced palmoplantar hyperkeratosis
    Lountzis, Nektarios I.
    Maroon, Michele S.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2008, 7 (06) : 588 - 589
  • [9] TAK1 is a novel therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance
    Xia, Shunjie
    Pan, Yu
    Xu, Junjie
    Cai, Xiujun
    JOURNAL OF HEPATOLOGY, 2020, 73 : S648 - S649
  • [10] Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity
    Bins, Sander
    Lenting, Anne
    El Bouazzaoui, Samira
    van Doorn, Leni
    Oomen-de Hoop, Esther
    Eskens, Ferry A. L. M.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    PHARMACOGENOMICS, 2016, 17 (14) : 1483 - 1490
12345